Literature DB >> 16804115

Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia.

Sanjana Dayal1, Katina M Wilson, Lorie Leo, Erland Arning, Teodoro Bottiglieri, Steven R Lentz.   

Abstract

Hyperhomocysteinemia is a risk factor for thrombosis, but the mechanisms are not well defined. We tested the hypothesis that hyperhomocysteinemia accelerates arterial thrombosis in mice. Mice heterozygous for a targeted disruption of the cystathionine beta-synthase gene (Cbs+/-) and wild-type littermates (Cbs+/+) were fed either a control diet or a high methionine/low folate (HM/LF) diet for 6 to 8 months to produce graded hyperhomocysteinemia. The time to occlusion of the carotid artery after photochemical injury was shortened by more than 50% in Cbs+/+ or Cbs+/- mice fed the HM/LF diet (P < .001 versus control diet). Carotid artery thrombosis was not accelerated in mice deficient in endothelial nitric oxide synthase (Nos3), which suggests that decreased endothelium-derived nitric oxide is not a sufficient mechanism for enhancement of thrombosis. Cbs+/+ and Cbs+/- mice fed the HM/LF diet had elevated levels of reactive oxygen species in the carotid artery, increased aortic expression of the NADPH oxidase catalytic subunit, Nox4, and decreased activation of anticoagulant protein C in the aorta (P < .05 versus control diet). We conclude that hyperhomocysteinemia enhances susceptibility to arterial thrombosis through a mechanism that is not caused by loss of endothelium-derived nitric oxide but may involve oxidative stress and impairment of the protein C anticoagulant pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804115      PMCID: PMC1895559          DOI: 10.1182/blood-2006-02-005991

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

Review 1.  Homocysteine and its disulfide derivatives: a suggested consensus terminology.

Authors:  S H Mudd; J D Finkelstein; H Refsum; P M Ueland; M R Malinow; S R Lentz; D W Jacobsen; L Brattström; B Wilcken; D E Wilcken; H J Blom; S P Stabler; R H Allen; J Selhub; I H Rosenberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Influence of folate on arterial permeability and stiffness in the absence or presence of hyperhomocysteinemia.

Authors:  J David Symons; Ussama B Zaid; Christian N Athanassious; Adam E Mullick; Steven R Lentz; John C Rutledge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-19       Impact factor: 8.311

4.  Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.

Authors:  S R Lentz; R A Erger; S Dayal; N Maeda; M R Malinow; D D Heistad; F M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-09       Impact factor: 4.733

5.  Characterization of a mouse model for thrombomodulin deficiency.

Authors:  H Weiler; V Lindner; B Kerlin; B H Isermann; S B Hendrickson; B C Cooley; D A Meh; M W Mosesson; N W Shworak; M J Post; E M Conway; L H Ulfman; U H von Andrian; J I Weitz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

6.  Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.

Authors:  S Yap; G H Boers; B Wilcken; D E Wilcken; D P Brenton; P J Lee; J H Walter; P M Howard; E R Naughten
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

7.  NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells.

Authors:  Olaf Herkert; Isabel Diebold; Ralf P Brandes; John Hess; Rudi Busse; Agnes Görlach
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

8.  Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.

Authors:  R T Eberhardt; M A Forgione; A Cap; J A Leopold; M A Rudd; M Trolliet; S Heydrick; R Stark; E S Klings; N I Moldovan; M Yaghoubi; P J Goldschmidt-Clermont; H W Farber; R Cohen; J Loscalzo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

9.  Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.

Authors:  S Dayal; T Bottiglieri; E Arning; N Maeda; M R Malinow; C D Sigmund; D D Heistad; F M Faraci; S R Lentz
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

10.  Effect of hyperhomocysteinemia on protein C activation and activity.

Authors:  Steven R Lentz; Donald J Piegors; José A Fernández; Rochelle A Erger; Erland Arning; M René Malinow; John H Griffin; Teodoro Bottiglieri; William G Haynes; Donald D Heistad
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

View more
  38 in total

1.  Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Authors:  Poulami Basu; Natia Qipshidze; Utpal Sen; Srikanth Givvimani; Charu Munjal; Paras K Mishra; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-08-13       Impact factor: 4.076

Review 2.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

3.  Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis.

Authors:  Thomas J Raife; Denis M Dwyre; Jeff W Stevens; Rochelle A Erger; Lorie Leo; Katina M Wilson; Jose A Fernández; Jennifer Wilder; Hyung-Suk Kim; John H Griffin; Nobuyo Maeda; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 4.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

5.  The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia.

Authors:  Patricia M DiBello; Sanjana Dayal; Suma Kaveti; Dongmei Zhang; Michael Kinter; Steven R Lentz; Donald W Jacobsen
Journal:  Mol Cell Proteomics       Date:  2009-12-14       Impact factor: 5.911

6.  Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.

Authors:  Roman N Rodionov; Hayan Dayoub; Cynthia M Lynch; Katina M Wilson; Jeff W Stevens; Daryl J Murry; Masumi Kimoto; Erland Arning; Teodoro Bottiglieri; John P Cooke; Gary L Baumbach; Frank M Faraci; Steven R Lentz
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

7.  Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.

Authors:  Sanjana Dayal; Roman N Rodionov; Erland Arning; Teodoro Bottiglieri; Masumi Kimoto; Daryl J Murry; John P Cooke; Frank M Faraci; Steven R Lentz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis.

Authors:  Sanjana Dayal; Katina M Wilson; David G Motto; Francis J Miller; Anil K Chauhan; Steven R Lentz
Journal:  Circulation       Date:  2013-02-20       Impact factor: 29.690

9.  Congenital MTHFR deficiency causing early-onset cerebral stroke in a case homozygous for MTHFR thermolabile variant.

Authors:  Seung Jin Kim; Beom Hee Lee; Yoo-Mi Kim; Gu-Hwan Kim; Han-Wook Yoo
Journal:  Metab Brain Dis       Date:  2013-03-23       Impact factor: 3.584

10.  Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction.

Authors:  Sophocles Chrissobolis; Sean P Didion; Dale A Kinzenbaw; Laura I Schrader; Sanjana Dayal; Steven R Lentz; Frank M Faraci
Journal:  Hypertension       Date:  2008-02-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.